Easier access to clinical trials for people with blood cancers
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
This project will build practical tools and expand nearby clinic sites so people with blood cancers can more easily find and join clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11160492 on NIH RePORTER |
What this research studies
You'll be helped by a new clinical trial toolkit that makes it easier for the cancer center to choose, run, and track trials; it includes feasibility metrics, a system to prioritize studies for resources, trackers for staff time and costs, and performance standards. The team will also work to offer trials at satellite clinics closer to where you live by building local leadership and a collaborative learning culture. Those satellite sites will use the same metrics so they enroll appropriate trials for their patient population. The aim is to reduce delays and give more patients access to promising treatments.
Who could benefit from this research
Good fit: Ideal candidates are people with hematologic malignancies (blood cancers) receiving care at or near the Sidney Kimmel Comprehensive Cancer Center or its affiliated satellite clinics who may be eligible for clinical trials.
Not a fit: Patients without blood cancers or those who do not meet eligibility rules for available trials are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, more patients with hematologic malignancies could access novel therapies closer to home and enroll in appropriate trials faster.
How similar studies have performed: Similar efforts to centralize trial feasibility metrics and offer trials at satellite sites have improved enrollment in some cancer programs, though results depend on local resources and study types.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Wagner-Johnston, Nina Delaney — Johns Hopkins University
- Study coordinator: Wagner-Johnston, Nina Delaney
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.